Exhibit 1.1
EXECUTION COPY
EXTRA SPACE STORAGE INC.
10,500,000 Shares
Common Stock
($.01 Par Value)
UNDERWRITING AGREEMENT
September 20, 2006
UNDERWRITING AGREEMENT
September 20, 2006
UBS Securities LLC
Banc of America Securities LLC
as Representatives of the several
Underwriters
c/o UBS Securities LLC
299 Park Avenue
New York, New York
10171
Ladies and Gentlemen:
Extra Space Storage Inc., a Maryland
corporation (the “Company”), and Extra Space Storage
LP, a Delaware limited partnership, of which the Company is the
indirect general partner and majority limited partner (the
“Operating Partnership” and, together with the Company,
the “Transaction Entities”), propose to issue and sell
to the underwriters named in Schedule A annexed hereto
(the “Underwriters”), for whom you are acting as
representatives, an aggregate of 10,500,000 shares (the “Firm
Shares”) of Common Stock, $.01 par value per share (the
“Common Stock”), of the Company. In addition, solely
for the purpose of covering over-allotments, the Transaction
Entities propose to grant to the Underwriters the option to
purchase from the Company up to an additional 1,575,000 shares of
Common Stock (the “Additional Shares”). The Firm
Shares and the Additional Shares are hereinafter collectively
sometimes referred to as the “Shares.” The Shares
are described in the Prospectus which is referred to
below.
The Company has prepared and filed,
in accordance with the provisions of the Securities Act of 1933, as
amended, and the rules and regulations thereunder (collectively,
the “Act”), with the Securities and Exchange Commission
(the “Commission”) a registration statement on Form
“S-3” (File No. 333-128970) under the Act (the
“registration statement”). Amendments to such
registration statement, if necessary or appropriate, have been
similarly prepared and filed with the Commission in accordance with
the Act. Such registration statement, as so amended, has
become effective under the Act.
Except where the context otherwise
requires, “Registration Statement,” as used herein,
means the registration statement, as amended at the time of such
registration statement’s effectiveness for purposes of
Section 11 of the Act, as such section applies to the respective
Underwriters (the “Effective Time”), including (i) all
documents filed as a part thereof or incorporated or deemed to be
incorporated by reference therein, (ii) any information contained
or incorporated by reference in a prospectus filed with the
Commission pursuant to Rule 424(b) under the Act, to the extent
such information is deemed, pursuant to Rule 430B or Rule 430C
under the Act, to be part of the registration statement at the
Effective Time, and (iii) any registration statement filed to
register the offer and sale of Shares pursuant to Rule 462(b) under
the Act.
The Company has furnished to you,
for use by the Underwriters and by dealers in connection with the
offering of the Shares, copies of one or more “preliminary
prospectus supplements,” and otherwise made available the
documents incorporated by reference therein, relating to the
Shares. Except where the context otherwise requires,
“Pre-Pricing Prospectus,” as used herein, means each
such preliminary prospectus “supplement,” in the form
so furnished, including any basic prospectus (whether or not in
preliminary form) furnished to you by the Company and attached to
or used with such preliminary
prospectus
“supplement.” Except where the context otherwise
requires, “Basic Prospectus,” as used herein, means any
such basic prospectus and any basic prospectus furnished to you by
the Company and attached to or used with the Prospectus Supplement
(as defined below).
Except where the context otherwise
requires, “Prospectus Supplement,” as used herein,
means the final prospectus supplement, relating to the Shares,
filed by the Company with the Commission pursuant to Rule 424(b)
under the Act on or before the second business day after the date
hereof (or such earlier time as may be required under the Act), in
the form furnished by the Company to you for use by the
Underwriters and by dealers in connection with the offering of the
Shares.
Except where the context otherwise
requires, “Prospectus,” as used herein, means the
Prospectus Supplement together with the Basic Prospectus attached
to or used with the Prospectus Supplement.
“Permitted Free Writing
Prospectuses,” as used herein, means the documents listed on
Schedule B attached hereto “and each “road
show” (as defined in Rule 433 under the Act), if any, related
to the offering of the Shares contemplated hereby that is a
“written communication” (as defined in Rule 405 under
the Act) (each such road show, a “Road
Show”).
“Disclosure Package,” as
used herein, means any Pre-Pricing Prospectus and Basic Prospectus,
in either case together with all Permitted Free Writing
Prospectuses, if any, and the information included as Schedule
C hereto (the “Pricing Information”).
Any reference herein to the
registration statement, the Registration Statement, any Basic
Prospectus, any Pre-Pricing Prospectus, the Prospectus Supplement,
the Prospectus or any Permitted Free Writing Prospectus shall be
deemed to refer to and include the documents, if any, incorporated
by reference, or deemed to be incorporated by reference, therein
(the “Incorporated Documents”), including, unless the
context otherwise requires, the documents, if any, filed as
exhibits to such Incorporated Documents. Any reference herein
to the terms “amend,” “amendment” or
“supplement” with respect to the Registration
Statement, any Basic Prospectus, any Pre-Pricing Prospectus, the
Prospectus Supplement, the Prospectus or any Permitted Free Writing
Prospectus shall be deemed to refer to and include the filing of
any document under the Securities Exchange Act of 1934, as amended,
and the rules and regulations thereunder (collectively, the
“Exchange Act”) on or after the initial effective date
of the Registration Statement, or the date of such Basic
Prospectus, such Pre-Pricing Prospectus, the Prospectus Supplement,
the Prospectus or such Permitted Free Writing Prospectus, as the
case may be, and deemed to be incorporated therein by
reference.
As used in this Agreement,
“business day” shall mean a day on which the New York
Stock Exchange (the “NYSE”) is open for trading.
The terms “herein,” “hereof,”
“hereto,” “hereinafter” and similar terms,
as used in this Agreement, shall in each case refer to this
Agreement as a whole and not to any particular section, paragraph,
sentence or other subdivision of this Agreement. The term
“or,” as used herein, is not exclusive.
1.
Sale and Purchase . Upon the basis of the
representations and warranties and subject to the terms and
conditions herein set forth, the Company agrees to issue and sell
to the respective Underwriters and each of the Underwriters,
severally and not jointly, agrees to purchase from the
2
Company the respective number of
Firm Shares (subject to such adjustment as UBS Securities LLC
(“UBS”) may determine to avoid fractional shares) which
bears the same proportion to the total number of Firm Shares to be
sold by the Company as the number of Firm Shares set forth opposite
the name of such Underwriter in Schedule A annexed
hereto, subject to adjustment in accordance with Section 8
hereof, in each case at a purchase price of $16.1925 per
Share. The Transaction Entities are advised by you that the
Underwriters intend (i) to make a public offering of their
respective portions of the Firm Shares as soon after the effective
date of this Agreement as in your judgment is advisable and (ii)
initially to offer the Firm Shares upon the terms set forth in the
Prospectus. You may from time to time increase or decrease
the public offering price after the initial public offering to such
extent as you may determine.
In addition, the Company hereby
grants to the several Underwriters the option (the
“Over-Allotment Option”) to purchase, and upon the
basis of the representations and warranties and subject to the
terms and conditions herein set forth, the Underwriters shall have
the right to purchase, severally and not jointly, from the Company
ratably in accordance with the number of Firm Shares to be
purchased by each of them, all or a portion of the Additional
Shares as may be necessary to cover over-allotments made in
connection with the offering of the Firm Shares, at the same
purchase price per share to be paid by the Underwriters to the
Company for the Firm Shares. The Over-Allotment Option may be
exercised by UBS on behalf of the several Underwriters at any time
and from time to time on or before the thirtieth day following the
date of the Prospectus Supplement, by written notice to the
Company. Such notice shall set forth the aggregate number of
Additional Shares as to which the Over-Allotment Option is being
exercised and the date and time when the Additional Shares are to
be delivered (any such date and time being herein referred to as an
“additional time of purchase”); provided ,
however , that no additional time of purchase shall be
earlier than the “time of purchase” (as defined below)
nor earlier than the second business day after the date on which
the Over-Allotment Option shall have been exercised nor later than
the tenth business day after the date on which the Over-Allotment
Option shall have been exercised. The number of Additional
Shares to be sold to each Underwriter shall be the number which
bears the same proportion to the aggregate number of Additional
Shares being purchased as the number of Firm Shares set forth
opposite the name of such Underwriter on Schedule A hereto
bears to the total number of Firm Shares (subject, in each case, to
such adjustment as UBS may determine to eliminate fractional
shares), subject to adjustment in accordance with Section 8
hereof.
2.
Payment and Delivery . Payment of the purchase price
for the Firm Shares shall be made to the Company by Federal Funds
wire transfer, against delivery of the certificates for the Firm
Shares to you through the facilities of The Depository Trust
Company (DTC) for the respective accounts of the
Underwriters. Such payment and delivery shall be made at
10:00 A.M., New York City time, on September 25,
2006 (unless another time shall be agreed to by you and the
Company or unless postponed in accordance with the provisions of
Section 8 hereof). The time at which such payment and
delivery are to be made is hereinafter sometimes called “the
time of purchase.” Electronic transfer of the Firm
Shares shall be made to you at the time of purchase in such names
and in such denominations as you shall specify.
Payment of the purchase price for
the Additional Shares shall be made at the additional time of
purchase in the same manner and at the same office as the payment
for the Firm Shares. Electronic transfer of the Additional
Shares shall be made to you at the additional time of purchase in
such names and in such denominations as you shall
specify.
3
Deliveries of the documents
described in Section 6 hereof with respect to the purchase of the
Shares shall be made at the offices of Hogan & Hartson L.L.P.,
555 Thirteenth Street, NW, Washington, D.C., at 9:00 A.M., New
York City time, on the date of the closing of the purchase of the
Firm Shares or the Additional Shares, as the case may
be.
3.
Representations and Warranties of the Transaction Entities
. Each of the Transaction Entities jointly and severally
represents and warrants to and agrees with each of the Underwriters
that:
(a)
the Registration Statement has heretofore become effective under
the Act; no stop order of the Commission preventing or suspending
the use of any Basic Prospectus, any Pre-Pricing Prospectus, the
Prospectus Supplement, the Prospectus or any Permitted Free Writing
Prospectus, or the effectiveness of the Registration Statement, has
been issued, and no proceedings for such purpose have been
instituted or, to the Company’s knowledge, are contemplated
by the Commission;
(b)
the Registration Statement complied when it became effective,
complies as of the date hereof and, as amended or supplemented, at
the time of purchase, each additional time of purchase, if any, and
at all times during which a prospectus is required by the Act to be
delivered (whether physically or through compliance with Rule 172
under the Act or any similar rule) in connection with any sale of
Shares, will comply, in all material respects, with the
requirements of the Act; the conditions to the use of Form
“S-3” in connection with the offering and sale of the
Shares as contemplated hereby have been satisfied; the Registration
Statement meets, and the offering and sale of the Shares as
contemplated hereby complies with, the requirements of Rule 415
under the Act (including, without limitation, Rule 415(a)(5)); the
Registration Statement did not, as of the Effective Time, contain
an untrue statement of a material fact or omit to state a material
fact required to be stated therein or necessary to make the
statements therein not misleading; each Pre-Pricing Prospectus
complied, at the time it was filed with the Commission, and
complies as of the date hereof, in all material respects with the
requirements of the Act; at no time during the period that begins
on the earlier of the date of such Pre-Pricing Prospectus and the
date such Pre-Pricing Prospectus was filed with the Commission and
ends at the time of purchase did or will any Pre-Pricing
Prospectus, as then amended or supplemented, together with the
Pricing Information, include an untrue statement of a material fact
or omit to state a material fact necessary in order to make the
statements therein, in the light of the circumstances under which
they were made, not misleading, and at no time during such period
did or will any Pre-Pricing Prospectus, as then amended or
supplemented, together with any combination of one or more of the
then issued Permitted Free Writing Prospectuses, if any, and the
Pricing Information, include an untrue statement of a material fact
or omit to state a material fact necessary in order to make the
statements therein, in the light of the circumstances under which
they were made, not misleading; each Basic Prospectus complied or
will comply, at the time it was or will be filed with the
Commission, complies as of the date hereof (if filed with the
Commission on or prior to the date hereof) and, at the time of
purchase, each additional time of purchase, if any, and at all
times during which a prospectus is required by the Act to be
delivered (whether physically or through compliance with Rule 172
under the Act or any similar rule) in connection with any sale of
Shares, will comply,
4
in all material respects, with the
requirements of the Act; at no time during the period that begins
on the earlier of the date of such Basic Prospectus and the date
such Basic Prospectus was filed with the Commission and ends at the
time of purchase did or will any Basic Prospectus, as then amended
or supplemented, together with the Pricing Information, include an
untrue statement of a material fact or omit to state a material
fact necessary in order to make the statements therein, in the
light of the circumstances under which they were made, not
misleading, and at no time during such period did or will any Basic
Prospectus, as then amended or supplemented, together with any
combination of one or more of the then issued Permitted Free
Writing Prospectuses, if any, and the Pricing Information, include
an untrue statement of a material fact or omit to state a material
fact necessary in order to make the statements therein, in the
light of the circumstances under which they were made, not
misleading; each of the Prospectus Supplement and the Prospectus
will comply, as of the date that it is filed with the Commission,
the date of the Prospectus Supplement, the time of purchase, each
additional time of purchase, if any, and at all times during which
a prospectus is required by the Act to be delivered (whether
physically or through compliance with Rule 172 under the Act or any
similar rule) in connection with any sale of Shares, in all
material respects, with the requirements of the Act (in the case of
the Prospectus, including, without limitation, Section 10(a) of the
Act); at no time during the period that begins on the earlier of
the date of the Prospectus Supplement and the date the Prospectus
Supplement is filed with the Commission and ends at the later of
the time of purchase, the latest additional time of purchase, if
any, and the end of the period during which a prospectus is
required by the Act to be delivered (whether physically or through
compliance with Rule 172 under the Act or any similar rule) in
connection with any sale of Shares did or will any Prospectus
Supplement or the Prospectus, as then amended or supplemented,
include an untrue statement of a material fact or omit to state a
material fact necessary in order to make the statements therein, in
the light of the circumstances under which they were made, not
misleading; at no time during the period that begins on the date of
such Permitted Free Writing Prospectus and ends at the time of
purchase did or will any Permitted Free Writing Prospectus include
an untrue statement of a material fact or omit to state a material
fact necessary in order to make the statements therein, in the
light of the circumstances under which they were made, not
misleading; provided , however , that the Company
makes no representation or warranty with respect to any statement
contained in the Registration Statement, any Pre-Pricing
Prospectus, the Prospectus or any Permitted Free Writing Prospectus
in reliance upon and in conformity with information concerning an
Underwriter and furnished in writing by or on behalf of such
Underwriter through you to the Company expressly for use in the
Registration Statement, such Pre-Pricing Prospectus, the Prospectus
or such Permitted Free Writing Prospectus; each Incorporated
Document, at the time such document was filed with the Commission,
complied, in all material respects, with the requirements of the
Exchange Act and did not include an untrue statement of a material
fact or omit to state a material fact necessary in order to make
the statements therein, in the light of the circumstances under
which they were made, not misleading;
(c)
prior to the execution of this Agreement, the Company has not,
directly or indirectly, offered or sold any Shares by means of any
“prospectus” (within the meaning of the Act) or used
any “prospectus” (within the meaning of the Act)
in
5
connection with the offer or sale of
the Shares, in each case other than the Pre-Pricing Prospectus and
the Permitted Free Writing Prospectus, if any; the Company has not,
directly or indirectly, prepared, used or referred to any Permitted
Free Writing Prospectus except in compliance with Rules 164 and 433
under the Act; assuming that such Permitted Free Writing Prospectus
is so sent or given after the Registration Statement was filed with
the Commission (and after such Permitted Free Writing Prospectus
was, if required pursuant to Rule 433(d) under the Act, filed with
the Commission), the sending or giving, by any Underwriter, of any
Permitted Free Writing Prospectus will satisfy the provisions of
Rule 164 or Rule 433 (without reliance on subsections (b), (c) and
(d) of Rule 164); the conditions set forth in one or more of
subclauses (i) through (iv), inclusive, of Rule 433(b)(1) under the
Act are satisfied, and the registration statement relating to the
offering of the Shares contemplated hereby, as initially filed with
the Commission, includes a prospectus that, other than by reason of
Rule 433 or Rule 431 under the Act, satisfies the requirements of
Section 10 of the Act; neither the Company nor the Underwriters are
disqualified, by reason of subsection (f) or (g) of Rule 164 under
the Act, from using, in connection with the offer and sale of the
Shares, “free writing prospectuses” (as defined in Rule
405 under the Act) pursuant to Rules 164 and 433 under the Act; the
Company is not an “ineligible issuer” (as defined in
Rule 405 under the Act) as of the eligibility determination date
for purposes of Rules 164 and 433 under the Act with respect to the
offering of the Shares contemplated by the Registration Statement;
the parties hereto agree and understand that the content of any and
all “road shows” (as defined in Rule 433 under the Act)
related to the offering of the Shares contemplated hereby is solely
the property of the Company;
(d)
as of June 30, 2006, the Company had an authorized and outstanding
capitalization as set forth under the heading “Actual”
in the section of the Registration Statement, the Pre-Pricing
Prospectus and the Prospectus entitled “Capitalization”
(and any similar sections or information, if any, contained in any
Permitted Free Writing Prospectus), and, as of the time of purchase
and any additional time of purchase, as the case may be, the
Company shall have an authorized capitalization as set forth under
the heading “As Adjusted” in the section of the
Registration Statement, the Pre-Pricing Prospectus and the
Prospectus entitled “Capitalization” (and any similar
sections or information, if any, contained in any Permitted Free
Writing Prospectus); all of the issued and outstanding shares of
capital stock, including the Common Stock of the Company have been
duly authorized and validly issued and are fully paid and
non-assessable, have been issued in compliance with all federal and
state securities laws and were not issued in violation of any
preemptive right, resale right, right of first refusal or similar
right and no further approval or authority of the stockholders or
the Board of Directors of the Company are required for the issuance
and sale of the Shares;
(e)
the Company has been duly incorporated and is validly existing as a
corporation in good standing under the laws of the State of
Maryland, with full corporate power and authority to own, lease and
operate its properties and conduct its business as described in the
Registration Statement, the Pre-Pricing Prospectus, the Prospectus
and the Permitted Free Writing Prospectus, if any, to execute and
deliver this Agreement and to issue, sell and deliver the Shares as
contemplated herein;
6
(f)
the Company is duly qualified to do business as a foreign
corporation and is in good standing in each jurisdiction where the
ownership or leasing of its properties or the conduct of its
business requires such qualification, except where the failure to
be so qualified and in good standing would not, individually or in
the aggregate, have a material adverse effect on the business,
properties, financial condition, results of operations or prospects
of the Company and the Subsidiaries (as hereinafter defined) taken
as a whole (a “Material Adverse Effect”);
(g)
the Company has provided you complete and correct copies of the
articles of incorporation and the by-laws (or comparable
organizational documents) of the Company and its subsidiaries (as
defined under the Exchange Act) (each, a “Subsidiary”
and collectively, the “Subsidiaries”) and all
amendments thereto have been delivered to you and, except as set
forth in the exhibits to the Registration Statement or any
Incorporated Document, no changes therein will be made on or after
the date hereof through and including the time of purchase or, if
later, any additional time of purchase; the Company, through two
wholly-owned Subsidiaries, owned approximately 93.1% of the
outstanding units of partnership interest in the Operating
Partnership as of June 30, 2006; each “significant
subsidiary” of the Company as defined in Rule 405 of the
Securities Act, Extra Space Management, Inc. and ESS Holdings
Business Trust I (each, a “Significant Subsidiary” and
collectively, the “Significant Subsidiaries”) has been
duly organized and is validly existing as a corporation, limited
liability company, limited partnership or trust, as applicable, in
good standing under the laws of the jurisdiction of its
organization, with full power and authority to own, lease and
operate its properties and to conduct its business as described in
the Registration Statement, the Pre-Pricing Prospectus, the
Prospectus and the Permitted Free Writing Prospectus, if any; each
Subsidiary is duly qualified to do business as a foreign
corporation, limited liability company, limited partnership or
trust, as applicable, and is in good standing in each jurisdiction
where the ownership or leasing of its properties or the conduct of
its business requires such qualification, except where the failure
to be so qualified and in good standing would not, individually or
in the aggregate, have a Material Adverse Effect; the Company has
no “significant subsidiary,” other than as set forth in
Annex A hereto; the Operating Partnership has full power and
authority to execute and deliver this Agreement and to perform its
obligations as contemplated herein; all of the outstanding shares
of capital stock or other equity interests of each of the
Subsidiaries have been duly authorized and validly issued, are
fully paid and non-assessable, as applicable, and, with respect to
such securities, are owned directly or indirectly by the Company
subject to no security interest, other encumbrance or adverse
claims; and no options, warrants or other rights to purchase,
agreements or other obligations to issue or other rights to convert
any obligation into shares of capital stock or ownership interests
in the Subsidiaries are outstanding;
(h)
the Shares have been duly and validly authorized and, when issued
and delivered against payment therefor as provided herein, will be
duly and validly issued, fully paid and non-assessable and free of
statutory and contractual preemptive rights, resale rights, rights
of first refusal and similar rights;
7
(i)
the capital stock of the Company, including the Shares, conforms in
all material respects to the description thereof contained or
incorporated by reference in the Registration Statement, the
Pre-Pricing Prospectus, the Prospectus or any Permitted Free
Writing Prospectus, and the certificates for the Shares are in due
and proper form and the holders of the Shares will not be subject
to personal liability by reason of being such holders;
(j)
this Agreement has been duly authorized, executed and delivered by
each of the Transaction Entities;
(k)
neither the Company nor any of the Subsidiaries is in breach or
violation of or in default under (nor has any event occurred which
with notice, lapse of time or both would result in any breach of,
constitute a default under or give the holder of any indebtedness
(or a person acting on such holder’s behalf) the right to
require the repurchase, redemption or repayment of all or a part of
such indebtedness under) (A) its respective charter, by-laws,
limited liability company agreement or partnership agreement, or
(B) any indenture, mortgage, deed of trust, bank loan or credit
agreement or other evidence of indebtedness, or any license, lease,
contract or other agreement or instrument to which the Company or
any of the Subsidiaries is a party or by which any of them or any
of their properties may be bound or affected, except, in case of
(B), as would not have a Material Adverse Effect, and the
execution, delivery and performance of this Agreement, the issuance
and sale of the Shares and the consummation of the transactions
contemplated hereby will not conflict with, result in any breach or
violation of or constitute a default under (nor constitute any
event which with notice, lapse of time or both would result in any
breach of or constitute a default under) (x) the charter or by-laws
of the Company or any of the Subsidiaries, or (y) any indenture,
mortgage, deed of trust, bank loan or credit agreement or other
evidence of indebtedness, or any license, lease, contract or other
agreement or instrument to which the Company or any of the
Subsidiaries is a party or by which any of them or any of their
respective properties may be bound or affected, or any federal,
state, local or foreign law, regulation or rule or any decree,
judgment or order applicable to the Company or any of the
Subsidiaries, except, in case of (y), as would not, individually or
in the aggregate, have a Material Adverse Effect;
(l)
no approval, authorization, consent or order of or filing with any
federal, state, local or foreign governmental or regulatory
commission, board, body, authority or agency is required in
connection the issuance and sale of the Shares or the consummation
by the Company of the transactions contemplated hereby, other than
registration of the Shares under the Act, which has been or will be
effected, and any necessary qualification under the securities or
blue sky laws of the various jurisdictions in which the Shares are
being offered by the Underwriters or under the Conduct Rules of the
National Association of Securities Dealers (the
“NASD”);
(m)
except as set forth in the Registration Statement, the Pre-Pricing
Prospectus and the Prospectus, (i) no person has the right,
contractual or otherwise, to cause the Company to issue or sell to
it any shares of Common Stock or shares of any other capital stock
or other equity interests of the Company, (ii) no person has
any
8
preemptive rights, resale rights,
rights of first refusal or other rights to purchase any shares of
Common Stock or shares of any other capital stock or other equity
interests of the Company, and (iii) no person has the right to
act as an underwriter or as a financial advisor to the Company in
connection with the offer and sale of the Shares, in the case of
each of the foregoing clauses (i), (ii) and (iii), whether as a
result of the filing or effectiveness of the Registration Statement
or the sale of the Shares as contemplated thereby or otherwise; no
person has the right, contractual or otherwise, to cause the
Company to register under the Act any shares of Common Stock or
shares of any other capital stock or other equity interests of the
Company, other than registration rights granted in connection with
the OP Units issued to Jesse Morgan and family, which registration
rights are not and will not be exercisable as of the date of this
Agreement, the time of purchase or the additional time of purchase,
or to include any such shares or interests in the Registration
Statement or the offering contemplated thereby, whether as a result
of the filing or effectiveness of the Registration Statement or the
sale of the Shares as contemplated thereby or otherwise;
(n)
each of the Company and the Subsidiaries has all necessary
licenses, authorizations, consents and approvals and has made all
necessary filings required under any federal, state, local or
foreign law, regulation or rule, and has obtained all necessary
authorizations, consents and approvals from other persons, in order
to conduct its respective business, except as would not have a
Material Adverse Effect; neither the Company nor any of the
Subsidiaries is in violation of, or in default under, or has
received notice of any proceedings relating to revocation or
modification of, any such license, authorization, consent or
approval or any federal, state, local or foreign law, regulation or
rule or any decree, order or judgment applicable to the Company or
any of the Subsidiaries, except where such violation, default,
revocation or modification would not, individually or in the
aggregate, have a Material Adverse Effect;
(o)
all legal or governmental proceedings, affiliate transactions,
off-balance sheet transactions, contracts, licenses, agreements,
leases or documents of a character required to be described in the
Registration Statement, the Pre-Pricing Prospectus or the
Prospectus or to be filed as an exhibit to the Registration
Statement have been so described or filed as required;
(p)
there are no actions, suits, claims, investigations or proceedings
pending or threatened or, to the knowledge of any of the
Transaction Entities, contemplated to which the Company or any of
the Subsidiaries or any of their respective directors or officers
is a party or of which any of their respective properties is
subject at law or in equity, before or by any federal, state, local
or foreign governmental or regulatory commission, board, body,
authority or agency, except any such action, suit, claim,
investigation or proceeding which would not result in a judgment,
decree or order having, individually or in the aggregate, a
Material Adverse Effect or preventing consummation of the
transactions contemplated hereby;
(q)
Each of Ernst & Young LLP, the Company’s current public
accountants and PricewaterhouseCoopers LLP, the Company’s
former public accountants, whose report on the consolidated
financial statements of the Company and the Subsidiaries
is
9
included and incorporated by
reference in the Registration Statement, the Pre-Pricing Prospectus
and the Prospectus, is an independent public accountants as
required by the Act and the rules of the Public Company Accounting
Oversight Board (United States);
(r)
the audited financial statements included and incorporated by
reference in the Registration Statement, the Pre-Pricing
Prospectus, the Prospectus or any Permitted Free Writing
Prospectus, together with the related notes and schedules, present
fairly the consolidated financial position of the Company and the
Subsidiaries as of the dates indicated, and the consolidated
results of operations and cash flows of the Company and the
Subsidiaries for the periods specified, and have been prepared in
compliance with the requirements of the Act and in conformity with
generally accepted accounting principles applied on a consistent
basis during the periods involved;
(s)
all pro forma financial statements or data included or incorporated
by reference in the Registration Statement, the Pre-Pricing
Prospectus, the Prospectus and any Permitted Free Writing
Prospectus comply with the requirements of Regulation S-X of the
Act and the Exchange Act and the assumptions used in the
preparation of such pro forma financial statements and data are
reasonable, the pro forma adjustments used therein are appropriate
to give effect to the transactions or circumstances described
therein and the pro forma adjustments have been properly applied to
the historical amounts in the compilation of those statements and
data; the other financial and statistical data contained or
incorporated by reference in the Registration Statement, the
Pre-Pricing Prospectus, the Prospectus and any Permitted Free
Writing Prospectus are accurately presented and prepared on a basis
consistent with the financial statements and books and records of
the Company; there are no financial statements (historical or pro
forma) that are required to be included or incorporated by
reference in the Registration Statement, the Pre-Pricing
Prospectus, the Prospectus and any Permitted Free Writing
Prospectus that are not included or incorporated by reference as
required; the Company and the Subsidiaries do not have any material
liabilities or obligations, direct or contingent (including any
off-balance sheet obligations), not disclosed in the Registration
Statement, the Pre-Pricing Prospectus, the Prospectus and any
Permitted Free Writing Prospectus; and all disclosures contained or
incorporated by reference in the Registration Statement, the
Pre-Pricing Prospectus, the Prospectus or any Permitted Free
Writing Prospectus regarding “non-GAAP financial
measures” (as such term is defined by the rules and
regulations of the Commission) comply with Regulation G of the
Exchange Act and Item 10 of Regulation S-K under the Act, to the
extent applicable;
(t)
subsequent to the respective dates as of which information is given
in the Registration Statement, the Pre-Pricing Prospectus, the
Prospectus and the Permitted Free Writing Prospectus, if any, in
each case excluding any amendments or supplements to the foregoing
made after the execution of this Agreement (such respective dates,
the ”Information Dates”), there has not been (i)
any material adverse change, or any development involving a
prospective material adverse change, in the business, properties,
management, financial condition or results of operations of the
Company and the Subsidiaries taken as a whole, (ii) any transaction
which is
10
material to the Company and the
Subsidiaries taken as a whole, (iii) any obligation, direct or
contingent (including any off-balance sheet obligations), incurred
by the Company or the Subsidiaries, which is material to the
Company and the Subsidiaries taken as a whole, (iv) other than the
issuance of shares of Common Stock pursuant to the exercise or
vesting of any Awards outstanding at the relevant Information Date
and issued pursuant to the Equity Plans, any change in the
authorized or outstanding capital stock or outstanding indebtedness
of the Company or the Subsidiaries or (v) any dividend or
distribution of any kind declared, paid or made on the capital
stock of the Company, other than the Common Stock dividend declared
by the Board of Directors of the Company on August 23, 2006 and
payable on September 29, 2006 to stockholders of record;
(u)
the Company has obtained for the benefit of the Underwriters the
agreement (a “Lock-Up Agreement”), in the form set
forth as Exhibit A hereto, of each of its directors and
officers identified in Exhibit A-1 hereto;
(v)
the Company is not and, after giving effect to the offering and
sale of the Shares, will not be an “investment company”
or an entity “controlled” by an “investment
company,” as such terms are defined in the Investment Company
Act of 1940, as amended (the “Investment Company
Act”);
(w)
except as described in the Registration Statement, the Pre-Pricing
Prospectus, the Prospectus or any Permitted Free Writing
Prospectus, the Company and each of the Subsidiaries has good and
marketable title to all property (real and personal) described the
Registration Statement and in the Prospectus as being owned by each
of them, free and clear of all liens, claims, security interests or
other encumbrances; except as described in the Registration
Statement, the Pre-Pricing Prospectus, the Prospectus or any
Permitted Free Writing Prospectus, all the property described in
the Registration Statement, the Pre-Pricing Prospectus, the
Prospectus or any Permitted Free Writing Prospectus as being held
under lease by the Company or a Subsidiary is held thereby under
valid, subsisting and enforceable leases, except where failure to
do so would not, individually or in the aggregate, have a Material
Adverse Effect;
(x)
except as described in the Registration Statement, the Pre-Pricing
Prospectus, the Prospectus and any Permitted Free Writing
Prospectus, the Company and the Subsidiaries own, or have obtained
valid and enforceable licenses for, or other rights to use, the
inventions, patent applications, patents, trademarks (both
registered and unregistered), tradenames, copyrights, trade secrets
and other proprietary information described in the Registration
Statement, the Pre-Pricing Prospectus, the Prospectus and any
Permitted Free Writing Prospectus as being owned or licensed by
them or which are necessary for the conduct of their respective
businesses, except where the failure to own, license or have such
rights would not, individually or in the aggregate, have a Material
Adverse Effect (such owned intellectual property, ownership rights,
licenses or rights to use, collectively, ”Intellectual
Property”); (i) there are no third parties who have or,
to the knowledge of any of the Transaction Entities, will be able
to establish rights to any Intellectual Property, except for the
ownership rights of the owners of the Intellectual Property which
is licensed to the Company and for licenses for or other rights to
use Intellectual Property which is licensed to the Company on a
non-exclusive basis; (ii) neither the Company nor any of the
Subsidiaries has received written notice of any infringement by
third parties of any Intellectual Property; (iii) there is no
pending or, to
11
the knowledge of the Transaction
Entities, threatened action, suit, proceeding or claim by others
challenging the Company’s rights in or to any Intellectual
Property, and the Company is unaware of any facts which could form
a reasonable basis for any such claim; (iv) there is no
pending or, to the knowledge of the Transaction Entities,
threatened action, suit, proceeding or claim by others challenging
the validity or scope of any Intellectual Property, and the Company
is unaware of any facts which could form a reasonable basis for any
such claim; (v) there is no pending or, to the knowledge of
the Transaction Entities, threatened action, suit, proceeding or
claim by others that the Company infringes or otherwise violates
any patent, trademark, copyright, trade secret or other proprietary
rights of others, and the Company is unaware of any facts which
could form a reasonable basis for any such claim; (vi) there
is no patent or patent application that contains claims that
interfere with the issued or pending claims of any of the
Intellectual Property; and (vii) neither the Company nor any of the
Subsidiaries is aware of any prior art that may render any patent
application owned by the Company of the Intellectual Property
unpatentable that has not been disclosed to the U.S. Patent and
Trademark Office;
(y)
neither the Company nor any of the Subsidiaries is engaged in any
unfair labor practice; except for matters which would not,
individually or in the aggregate, have a Material Adverse Effect,
(i) there is (A) no unfair labor practice complaint
pending or, to the knowledge of any of the Transaction Entities,
threatened against the Company or any of the Subsidiaries before
the National Labor Relations Board, and no grievance or arbitration
proceeding arising out of or under collective bargaining agreements
is pending or threatened, (B) no strike, labor dispute,
slowdown or stoppage pending or, to the knowledge of any of the
Transaction Entities, threatened against the Company or any of the
Subsidiaries and (C) no union representation dispute currently
existing concerning the employees of the Company or any of the
Subsidiaries, and (ii) to the knowledge of any of the
Transaction Entities, (A) no union organizing activities are
currently taking place concerning the employees of the Company or
any of the Subsidiaries and (B) there has been no violation of
any federal, state, local or foreign law relating to discrimination
in the hiring, promotion or pay of employees, any applicable wage
or hour laws or any provision of the Employee Retirement Income
Security Act of 1974 (“ERISA”) or the rules and
regulations promulgated thereunder concerning the employees of the
Company or any of the Subsidiaries;
(z)
(i) the Company and the Subsidiaries and their properties, assets
and operations are in compliance with, and hold all permits,
authorizations and approvals required under, Environmental Laws (as
defined below), except to the extent that failure to so comply or
to hold such permits, authorizations or approvals would not,
individually or in the aggregate, have a Material Adverse Effect;
(ii) there are no past, present or, to the knowledge of any of the
Transaction Entities, reasonably anticipated future events,
conditions, circumstances, activities, practices, actions,
omissions or plans that could reasonably be expected to give rise
to any material costs or liabilities to the Company or the
Subsidiaries under, or to interfere with or prevent compliance by
the Company or the Subsidiaries with, Environmental Laws; (iii)
except as would not, individually or in the aggregate, have a
Material Adverse Effect, neither the Company nor any of the
Subsidiaries (A) is the subject of any investigation, (B) has
received any notice or claim,
12
(C) is a party to or affected by any
pending or threatened action, suit or proceeding, (D) is bound by
any judgment, decree or order or (E) has entered into any
agreement, in each case relating to any alleged violation of any
Environmental Law or any actual or alleged liability or release or
threatened release or cleanup at any location of any Hazardous
Materials (as defined below) (as used herein, “Environmental
Law” means any federal, state, local or foreign law, statute,
ordinance, rule, regulation, order, decree, judgment, injunction,
permit, license, authorization or other binding requirement, or
common law, relating to health, safety or the protection, cleanup
or restoration of the environment or natural resources, including
those relating to the distribution, processing, generation,
treatment, storage, disposal, transportation, other handling or
release or threatened release of Hazardous Materials, and
“Hazardous Materials” means any material (including,
without limitation, pollutants, contaminants, hazardous or toxic
substances or wastes) that is regulated by or may give rise to
liability under any Environmental Law);
(aa)
in the ordinary course of its business, the Company conducts a
periodic review of the effect of the Environmental Laws on the
business, operations and properties of the Company and each of its
Subsidiaries, in the course of which it identifies and evaluates
associated costs and liabilities (including, without limitation,
any capital or operating expenditures required for cleanup, closure
of properties or compliance with the Environmental Laws or any
permit, license or approval, any related constraints on operating
activities and any potential liabilities to third
parties);
(bb)
all material tax returns required to be filed by the Company and
each of the Subsidiaries have been filed, and all material taxes
and other assessments of a similar nature (whether imposed directly
or through withholding) including any interest, additions to tax or
penalties applicable thereto due or claimed to be due from such
entities have been paid, other than those being contested in good
faith and for which adequate reserves have been provided; the
Company has no knowledge of any tax deficiency that has been
asserted or threatened against the Company or any Subsidiary or of
any current audit of any tax return of the Company or a Subsidiary
by a federal, state or local taxing authority or agency;
(cc)
the Company has been organized and has operated in conformity with
the requirements for qualification as a real estate investment
trust (“REIT”) pursuant to Sections 856 through 860 of
the In